Mutations in the profilin 1 (PFN1) gene are causative for familial amyotrophic lateral sclerosis (fALS). However, it is still not fully understood how these mutations lead to neurodegeneration. To address this question, we generated a novel Drosophila model expressing human wild-type and ALS-causative PFN1 mutants. We show that at larval neuromuscular junctions (NMJ), motor neuron expression of wild-type human PFN1 increases the number of ghost boutons, active zone density, Factin content, and the formation of filopodia. In contrast, the expression of ALS-causative human PFN1 mutants causes a less pronounced phenotype, suggesting a loss of function of these mutants in promoting NMJ remodeling. Importantly, expression of human PFN1 in motor neurons results in progressive locomotion defects and shorter lifespan in adult flies, while ALScausative PFN1 mutants display a less toxic effect. In summary, our study provides evidence that PFN1 is important in regulating NMJ morphology and influences survival and locomotion in Drosophila. Furthermore, our results suggest ALS-causative human PFN1 mutants display a partial loss of function relative to wild-type hPFN1 that may contribute to human disease pathogenesis.
Introduction
Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative disease that results in both upper and lower motor neuron death. Approximately, 90% of ALS cases are sporadic (sALS), and 10% are familial (fALS) (1) . We have previously shown that mutations in the PFN1 gene are causative for fALS (2) . Profilin 1 (PFN1) is ubiquitously expressed in non-muscle cells and functions as a major regulator of actin polymerization through three proposed mechanisms (3) . First, PFN1 binds to monomeric actin-ADP (G-actin), thus regulating the pool of free actin in the cell. Second, it enhances the conversion of actin-ADP to actin-ATP. Lastly, it brings monomeric actin to the growing end of the actin filament (F-actin) through its interactions with formins.
Ubiquitinated, insoluble aggregates are a pathological hallmark of ALS. Our previous study demonstrated that mutant PFN1 forms ubiquitinated aggregates in both immortalized cell lines and murine primary motor neurons (2) , which results from a decrease in the stability of the mutant protein (4) . The formation of these aggregates suggests mutant PFN1 may contribute to ALS pathogenesis through a toxic gain of function. Supporting this hypothesis, expression of the aggregationprone mutant C71G, but not wild-type human PFN1 (WT hPFN1), leads to motor neuron loss, paralysis, and premature death in mice (5) . Furthermore, overexpression of mutant hPFN1 exacerbates retinal degeneration caused by the expression of human TDP-43 in Drosophila. Neither the expression of WT hPFN1 nor knockdown of chickadee (chic), the Drosophila homologue of PFN1, were able to cause such effects (6) . In contrast, there is evidence that mutations in PFN1 may induce toxicity through a loss of function. All causative mutations identified in our original study (C71G, G118V, and M114T) have been found in proximity to the actin binding domain and display decreased bound actin levels (2) . Expression of mutant PFN1 in primary motor neurons causes shorter neurite length and smaller growth cone area with decreased F-actin/G-actin ratios (2) , suggesting that reduced actin dynamics may contribute to disease pathogenesis. Furthermore, growth defects induced by deletion of the yeast PFN1 ortholog were capable of being rescued by the expression of WT hPFN1 but not ALScausative mutants (7) , arguing for a "loss of function" mechanism.
Drosophila melanogaster has been widely used to model neurodegenerative diseases, including ALS (8, 9) . In particular, fly larval NMJ is a well-established system for studying synaptic functions and morphology (10) . Termini of larval segmental nerves form a series of varicosities where they contact and innervate muscles. These "boutons" contain active zones where neurotransmitters are released and have a stereotyped beadson-a-string pattern. Previous studies reported various NMJ phenotypes in different ALS fly models (11) (12) (13) (14) (15) , highlighting the importance of NMJ homeostasis in ALS pathogenesis. Of note, normal synaptic morphology and functions rely on an intact actin network and mutations in the components of the actin cytoskeleton have been shown to cause abnormal larval NMJ morphologies (16) (17) (18) , suggesting that NMJ integrity and maintenance could be a primary pathway altered by mutant PFN1.
To address this hypothesis and increase our comprehension of neurodegeneration in vivo, we have developed a novel Drosophila model expressing either wild-type (WT) or mutant human PFN1 (hPFN1). We demonstrate that expression of WT hPFN1 in motor neurons results in a rise in F-actin levels at the larval NMJ, an increase in filopodia and ghost bouton numbers, and an increased presence of the active zone protein bruchpilot (BRP). WT hPFN1 expression also resulted in a decrease in satellite boutons and synaptic vesicles. In adults, climbing defects and reduced survival were also observed. With the exception of an increases in BRP at the NMJ, examination of Drosophila expressing mutant hPFN1 revealed similar phenotypic alterations to those expressing WT. Several of these defects were more pronounced in the WT hPFN1 expressing flies relative to the mutant expressing flies. Taken together, our data suggest that mutant PFN1 may display partial loss of function properties compared to the WT protein. This information provides valuable insight into the pathogenesis of ALS resulting from mutations in PFN1.
Results

A Drosophila model expressing hPFN1
To characterize the contribution of ALS-causative PFN1 mutations to neurodegeneration in vivo, we generated a transgenic Drosophila model expressing hPFN1 with an N-terminal V5 tag, using the Gal4/UAS system. Fly lines with similar expression levels among genotypes were selected for further experiments ( Fig. 1A and B) . The hPFN1 protein and its Drosophila ortholog chic display a low level of homology (21.1% identity, 39.4% similarity) (Fig. 1C) . However, previous studies have shown that PFN1 from several species share high similarity in their threedimensional structure, despite a low level of sequence homology (19) (20) (21) . Furthermore, hPFN1 is capable of substituting for yeast PFN1 (Pfy) in functional assays (7) . Similarly, we investigated whether hPFN1 can functionally substitute for Drosophila chic. Chic is an essential gene, as deletion mutants do not survive past the embryonic stage (22) . Interestingly, we found that reducing chic expression in motor neurons, through cellspecific knockdown (KD) by RNAi using an OK371-Gal4 driver, was sufficient to cause lethality at the pupal stage (data not shown). Expression of either WT or mutant hPFN1 in chic KD motor neurons was sufficient to rescue the pupal lethality (Fig. 1D) . To serve as a control for UAS transgene expression and the possibility that chic KD may be reduced due to the dilution of Gal4 proteins the ability of mCD8-GFP expression to rescue pupal lethality under the same RNAi background was examined. The expression of mCD8-GFP was unable to rescue the phenotype. These results suggest that hPFN1 can functionally replace Drosophila chic in motor neurons. Furthermore, the ability of mutant hPFN1 to fully rescue pupal death suggests that these mutants are functional to some degree at early developmental stages.
Mutant hPFN1 does not form aggregates in Drosophila motor neurons
Expression of ALS-causative hPFN1 mutants in cultured cells, including primary motor neurons, induces the formation of ubiquitinated aggregates that are not present upon overexpression of WT hPFN1 (2, 23) . Therefore, we investigated whether mutant hPFN1 also led to protein aggregation in vivo in our Drosophila model. To test this, we expressed either WT or mutant hPFN1 in motor neurons using the OK371-Gal4 driver and stained larval ventral nerve cords. We did not detect visible aggregate formation of WT or mutant hPFN1 in larvae ( Fig. 2A) . We further attempted to detect aggregate formation in adult flies by expressing WT or mutant hPFN1 under the same driver and examining the presence of hPFN1 in Triton X-100 soluble and insoluble fractions by western blotting (Fig. 2B ). Similar to our results in the larval ventral nerve cords, we did not detect WT or mutant hPFN1 in the insoluble fraction. Similarly, expression of hPFN1 using the tubulin-Gal4 driver also did not lead to the formation of aggregates in adult flies (Supplementary Material, Fig. S1 ). Taken together, these results demonstrate that in our model, neither WT nor mutant hPFN1 form aggregates in vivo throughout the Drosophila lifespan.
Expression of hPFN1 in motor neurons alters the larval NMJ morphology
To examine if mutant hPFN1 function is impaired in motor neurons in vivo, we examined the morphology of NMJs on muscle 4. The NMJ was visualized by immunostaining for HRP, which labels neuronal membranes, and Dlg, a post-synaptic marker. Expression of hPFN1, either WT or mutant, under the control of the OK371-Gal4 driver did not alter the number and size of major boutons (Fig. 3A-C) . However, expression of WT hPFN1 increased the number of boutons that were stained positive for HRP but not post-synaptic Dlg ( Fig. 3D and E) . These boutons, termed ghost boutons, are not functional synapses as they lack active zones and post-synaptic markers, despite the presence of synaptic vesicles (24) . Increase in ghost bouton numbers were also observed upon expression of mutant hPFN1, though to a lesser degree than WT. M114T hPFN1 expressing motor neurons possessed significantly less ghost boutons than WT, while hPFN1 C71G expressing motor neurons displayed a trend towards decreased ghost boutons as compared to WT (Fig. 3E) . Furthermore, we observed that expression of either WT or mutant hPFN1 reduced the basal number of satellite boutons. Unlike ghost boutons, satellite boutons contain active zones and are opposed by post-synaptic markers (25) , suggesting a difference in functional property between these two types of boutons. In contrast to the ghost bouton number, WT and mutant hPFN1 induced reduction of satellite boutons at similar levels ( Fig. 3F and G) .
Regulation of pre-synaptic proteins is changed by the expression of hPFN1
To further investigate the effects of WT and mutant PFN1 expression on NMJ morphology and function, we measured the levels of the pre-synaptic proteins cysteine string protein (CSP) and bruchpilot (BRP). CSP associates with the membrane of synaptic vesicles (26) and BRP is necessary for the assembly and function of active zones (27, 28) . When compared to control flies, a significant decrease in CSP staining was observed in both WT and mutant hPFN1 expressing flies. Conversely, BRP overall levels and BRP puncta density were significantly increased at the NMJ upon expression of WT hPFN1 ( Fig. 4C-E) . Those phenotypes were not mimicked in flies expressing mutant hPFN1 ( Fig.  4C-E) . Overall, these results suggest that PFN1 has diverse roles in pre-synaptic regulation at the NMJ and that mutant PFN1 expression can lead to altered pre-synaptic regulation when compared to the expression of WT hPFN1.
hPFN1 expression in motor neurons increases F-actin and filopodia formation
Given that PFN1 is a positive regulator of actin polymerization, and the actin cytoskeleton is essential for the maintenance and function of the NMJ (11-13), we investigated whether actin dynamics were altered due to the expression of WT and mutant hPFN1. Towards this goal, we utilized UAS-Lifeact-GFP transgenic flies to examine F-actin content in the axon terminal of motor neurons at the larval NMJ. Lifeact is a 17-amino acid peptide that binds to F-actin and has been used widely to monitor F-actin dynamics in vivo (29, 30) . When compared to control flies, the co-expression of Lifeact-GFP with hPFN1 in motor neurons led to a significant increase in Lifeact-GFP signal at the axon terminal, reflecting an increase in F-actin content. Expression of both C71G and M114T similarly displayed an increase in Lifeact-GFP signal relative to control flies, though only the C71G mutant reached statistical significance ( Fig. 5A and B) . Lifeact-GFP staining also revealed the presence of F-actin rich and HRP-positive filopodia at the NMJ in the hPFN1 flies, whereas filopodia were absent in control NMJs ( Fig. 5A and C). The majority of the filopodia observed in WT and mutant expressing motor neurons were positive for BRP (Supplementary Material, Fig. S2 ). This is similar to other actin rich filopodia reported at the Drosophila NMJ (16) . The WT expressing flies showed the greatest increase in the number of filopodia followed by the C71G and M114T mutants (Fig. 5C ). No differences were observed in the length of filopodia between WT and mutant hPFN1 expressing NMJs (Fig. 5D ).
hPFN1 expression leads to adult locomotion defects and reduces lifespan
To examine if changes at the larval NMJ due to hPFN1 expression resulted in motor dysfunction, we conducted larval crawling assays. All 3 rd instar PFN1-expressing larvae demonstrated normal crawling ability compared to control larvae (Supplementary Material, Fig. S3 ). We then expanded our studies to determine whether hPFN1 expression would cause locomotion defects at adult age, possibly reflecting the adultonset motor dysfunction present in ALS. Negative geotaxis is a behavior commonly measured in ALS Drosophila models to 
study effects of ALS-associated genes on adult locomotion (31) . As such, we investigated the effects of hPFN1 expression on negative geotaxis. At 5 days post-eclosion (d.p.e.), flies expressing WT and M114T hPFN1 had climbing abilities similar to driver-only controls, while there was a mild reduction in flies expressing hPFN1 C71G. At 10 d.p.e., all hPFN1-expressing flies displayed significant climbing defects, and by day 20, almost no hPFN1 transgenic flies could be observed climbing (Fig. 6A) . The expression of hPFN1, both mutant and WT, reproducibly led to a similar phenotype whether the hPFN1 gene had integrated on the second or third chromosome (Supplementary Material, Fig.  S4A and B) , providing evidence that the motor dysfunction observed was due to the expression of hPFN1 and not the site of insertion of the transgene. In parallel to locomotion defects, the expression of WT hPFN1 in motor neurons led to significant toxicity, as indicated by a dramatic reduction in lifespan. Similarly, the survival of C71G and M114T hPFN1 expressing flies was also reduced, but not to the same degree of the WT hPFN1 expressing flies (Fig. 6B) . We further investigated whether hPFN1 could induce cell toxicity when expressed in photoreceptor cells using the GMR-Gal4 driver. Consistent with recently reported results (6), we were unable to detect any obvious degeneration in the eye when expressing WT or mutant C71G hPFN1 (Supplementary Material, Fig. S5 ), suggesting that this defect may be specific to motor neurons.
Our results demonstrate that expression of hPFN1 in fly motor neurons leads to cell type-specific toxicity, with WT hPFN1 displaying a more dramatic effect relative to mutant PFN1. To determine whether these results were due to the ectopic expression of the human protein, we compared its toxicity with that of hPFN1 Drosophila ortholog chic. Towards this end, we generated flies which expressed exogenous chic at a similar level to hPFN1 in our Drosophila model (Supplementary Material, Fig. S6A ). Western blotting revealed that the level of expression of exogenous chic is more than twice of the endogenous chic. As with the expression of hPFN1, the expression of exogenous chic at the larval NMJ led to the formation of F-actin rich filopodia, though overall there was no significant increase in Lifeact-GFP intensity as observed with WT and C71G hPFN1 expression (Supplementary Material, Fig. S6B-D) . Interestingly, similar defects in the negative geotaxis assay and lifespan were present in chic overexpressing flies to those expressing WT hPFN1 (Supplementary Material, Fig. S6E and F) . This suggests the toxicity caused by expression of hPFN1 is not due to the expression of an ectopic human protein, but rather by the dysregulation of cellular pathways in which native chic is involved.
Discussion
We have established and characterized a novel Drosophila model expressing either WT or mutant hPFN1 in order to elucidate the pathogenic mechanisms underlying neurodegeneration in ALS. Although hPFN1 and its Drosophila ortholog chic are not highly conserved, we demonstrated that hPFN1 is capable of rescuing pupal death caused by chic knockdown in motor neurons. Similarly, it has been previously demonstrated that WT hPFN1 can rescue growth defects caused by mutations in the yeast PFN1 ortholog (7) . Our results further demonstrate that PFN1 is functionally conserved throughout evolution.
Ubiquitinated, insoluble aggregates are a hallmark of ALS. Nonetheless, the role of these aggregates in the pathogenesis of the disease is unclear. Under our experimental conditions, hPFN1 expressing flies do not contain detectable aggregates at any time points examined, including when flies show extreme motor dysfunction and decreased survival. Drosophila models expressing ALS-linked proteins known to aggregate in human motor neurons have been found to be both positive (15, (31) (32) (33) and negative (34) for aggregates. The presence of aggregates in culture and the absence in vivo may be caused by numerous factors, including expression levels, cell type, or simply differences between fly protein degradation pathways compared to other species. Regardless, our model provides a system to examine mutant hPFN1's role in ALS without the presence of aggregates, allowing us to identify important pathways contributing to ALS pathogenesis. Our data further reveal that hPFN1, both WT and mutant, can induce toxicity in motor neurons, suggesting that PFN1 regulation is critical for proper neuronal development and survival. The ability of hPFN1 to induce toxicity in motor neurons without the presence of aggregates supports recent data in mutant PFN1 transgenic mice. In this mouse model, motor neuron degeneration precedes the accumulation of mutant hPFN1 aggregates, suggesting mutant PFN1 aggregation does not trigger disease onset (5) . The use of our model in future screens will be pivotal to identify pathogenic changes in mutant hPFN1 function that are not dependent on aggregates, leading to a better understanding of how both soluble hPFN1 and aggregates contribute to disease progression. PFN1 is present both in presynaptic (35) and postsynaptic (36) compartments of neurons. It is involved in various aspects of neuronal function, including promoting axonal outgrowth of motor neurons in Drosophila embryos (37) . To investigate how hPFN1 mutants affect motor neurons, we expressed WT or mutant hPFN1 in larval NMJs. First, we observed a decrease in satellite boutons. Increased actin assembly mediated by the bone morphogenic protein (BMP) signaling has been previously implicated in the formation of satellite boutons (24) . Consistent with its role as a regulator of actin dynamics, expression of hPFN1 led to increased F-actin levels at the NMJ. However, we observed an opposite effect on satellite bouton formation, suggesting this phenotype may be caused by a different mechanism than simply altered actin dynamics. PFN1 expression has been demonstrated to be downregulated by BMP signaling in osteoblasts and PFN1 also suppresses BMP induced osteoblast differentiation (38) . Therefore, one possibility is that hPFN1 acts as an antagonist to BMP signaling that influences satellite bouton formation.
Expression of hPFN1 led to an increase in ghost boutons and filopodia, both of which are not apposed by the post-synaptic marker Dlg. Dlg clusters at the synapse after innervation from the presynaptic cell (39) . The presence of hPFN1 does not alter the quantity of major boutons so it is highly unlikely that either of these structures become major boutons. Therefore, both the ghost boutons and filopodia induced by hPFN1 are most likely unable to properly innervate muscle and alter muscular function at the larval stage. The formation of ghost boutons and filopodia in our model may be actin dependent. Actin bundling plays a role in the formation of ghost boutons (40) and increased filopodia formation occurs when hts/adducin, an actin capping protein, is depleted in larval NMJs (16) . We found the average length of the filopodia to be unchanged in the presence of hPFN1, suggesting PFN1 is involved in the formation or stabilization of filopodia, but not their elongation. A role for PFN1 in filopodia formation has been reported in mouse embryonic fibroblasts (41) . Increases in ghost boutons and filopodia number have been reported in larval NMJs when they undergo spaced high potassium stimulation (24) , suggesting PFN1 may have a role in activity dependent presynaptic remodeling. Our findings of the effects of WT hPFN1 on BRP also support this potential role of PFN1, as stimulation can lead to alterations in BRP (24, 42) . Future studies will be required to determine whether mutant PFN1 affects the ability of the NMJ to respond to acute stimulation, and if so, whether it is through an actin dependent process.
Upon expression of WT hPFN1, we observed changes in presynaptic proteins CSP and BRP. The alterations in these pre-synaptic proteins hints there may be changes to synaptic vesicles, active zones, and NMJ synaptic activity caused by the expression of hPFN1 in motor neurons. Interestingly, changes in BRP were not found in larvae expressing mutant hPFN1. Future work, including electron microscopy to visualize synaptic vesicles and electrophysiology, will need to be performed to get a more extensive characterization as to the extent which WT hPFN1 expression affects synaptic vesicle density and synaptic activity at the larval NMJ and how these effects may differ upon expression of mutant hPFN1. Despite numerous changes at the NMJ, the expression of hPFN1 did not alter larval motor function nor did it alter the size and number of major boutons. ALS is an adult-onset neurodegenerative disorder and hPFN1 adult flies display motor abnormalities and decreased survival. This suggests that the NMJ abnormalities present in hPFN1 expressing larvae may become intensified with aging, a known risk factor for neurodegenerative diseases such as ALS, leading to additional morphological changes and toxicity at the adult NMJ.
Interestingly, our study revealed that mutant hPFN1 expression had a smaller effect on the formation of F-actin rich filopodia, ghost bouton number, and active zone density when compared to WT hPFN1. These changes were also accompanied by decreased toxicity and a trend toward decreased motor dysfunction in adult Drosophila expressing ALS mutants compared to those expressing WT hPFN1. These results imply that mutant hPFN1 may contribute to ALS pathology through a partial loss of function mechanism. This hypothesis is supported by previous work in yeast in which expression of WT hPFN1, but not C71G and M114T mutants, was able to rescue growth defects in yeast profilin mutants (7) . The suggested loss of function of ALS mutants is only partial in our model, as mutant hPFN1 expression is able to rescue pupal death caused by the knockdown of chic. A recent study in Drosophila has suggested that mutant PFN1 may lead to pathogenesis through a gain of toxic function (6). Matsukawa et al. observed that expression of mutant hPFN1, but not WT, intensifies the eye phenotype present when hTDP-43 is expressed. As we have found, they also report that expression of mutant or WT hPFN1 was unable to produce eye degeneration when expressed alone. The ability of hPFN1 to induce toxicity when expressed in motor neurons and not in photoreceptor cells suggests that hPFN1's mode of action may depend on cell type. In addition, the gain of function observed by Matsukawa et al. is related to the presence of a pre-existing stress, i.e. TDP-43 overexpression. It is plausible that in ALS, mutant PFN1 can act through both a loss and gain of function. For example, the inability of mutant PFN1 to properly regulate actin dynamics or properly perform other functions may lead to alterations in TDP-43, such as mislocalization (6, 43) . Once mislocalization or other changes to TDP-43 occur, PFN1 may induce further toxicity mediated by a TDP-43-dependent gain of function.
Additional mechanisms besides actin dynamics may contribute to the phenotypes presented by the expression of hPFN1 in Drosophila motor neurons. PFN1 has been shown to bind to numerous ligands which serve various roles including synaptic scaffolding, endocytosis, cell signaling, and actin nuclear clearance (3) . hPFN1 may act as a link between its ligands and the actin cytoskeleton but also may act in an actin-independent manner. The importance and dynamics of the relationships between hPFN1 and many of its ligands are unknown in vivo. Our model will be beneficial for future studies aimed at identifying interactors of hPFN1, both WT and mutant, which are meaningful in vivo. These interactions will provide important additional information as to the function of hPFN1 and how those functions may be affected in ALS.
In conclusion, we have generated a Drosophila model expressing mutant and WT hPFN1 in motor neurons. Expression of both mutant and WT hPFN1 resulted in phenotypes that reflect symptoms in ALS patients. These phenotypes demonstrate a role for hPFN1 in regulating motor neuron morphology and function in vivo and suggest an increase in the influence of hPFN1 with aging. Future genetic screens using these phenotypes as readouts will be extremely useful in enhancing the understanding of how PFN1 regulates NMJ functions and how those functions are altered in ALS. Importantly, we also observed that the effect of ALS-causative hPFN1 mutants on several phenotypes was less severe than WT hPFN1. This suggests that a partial loss of function in PFN1 ALS-causative mutants may contribute to human disease pathogenesis.
Materials and Methods
Fly stocks and transgenic flies
All flies were maintained on standard fly food (molasses, cornmeal, yeast, and agar) at 25 C. To increase expression of transgenes, crosses were set at 25 C for 2 days and then shifted to 29 C afterwards in all experiments unless stated otherwise.
W 1118 strain was used as control flies. The V5 epitope tag and the coding region of hPFN1 and chic was subcloned into pUAST vector from constructs previously reported (2) to generate UAS-V5-hPFN1 transgenic flies. Purified constructs were sent for Drosophila embryo injection (BestGene Inc.) resulting in random insertion into the genome. The following stocks were obtained from Bloomington Stock Center: OK371-GAL4, repo-GAL4, GMR-GAL4, act5c-GAL4, tubulin-GAL4, UAS-mCD8-GFP, UAS-mcherry-NLS, UAS-Lifeact-GFP. RNAi line against chickadee (HMS00550) was obtained from TRiP RNAi Screening Center at Harvard Medical School.
Rescue of PFN1 knockdown lethality
Flies with the WT or mutant hPFN1 transgene on the second chromosome (lines PFN1 WT#1, PFN1 C71G#1, PFN1 M114T#5) were crossed to generate stocks homozygous for the transgene and heterozygous for TRiP.HMS00550 and the balancer chromosome TM6b on the third chromosome (hPFN1/hPFN1; TRiP. HMS00550/TM6b). These lines were crossed with lines homozygous for the OK371-Gal 4 driver on the second chromosome (hPFN1/hPFN1; TRiP. HMS00550/TM6b X OK371-Gal 4/OK371-Gal 4; þ/þ) to examine the ability of mutant and WT hPFN1 to rescue lethality induced by expression of TRiP.HMS00550. Offspring were scored by the presence of the Humeral marker, which is carried on the TM6b chromosome. Full rescue provided by hPFN1 expression would result in 50% of the offspring without the Humeral marker.
Western blotting
Heads of 10 male flies, aged 1-to-3-day olds, unless otherwise noted, were collected and homogenized in TNT lysis buffer (200mM Tris, pH 8, 150 mM NaCl, 1% Triton X-100). 5X SDS loading buffers (300mM Tris-HCl, 10% SDS, 37.5% glycerol, .025% Bromophenol Blue, 5% 2-mercaptoethanol) were added to the homogenates and equal quantities were loaded onto 4-20% SDS-PAGE (Bio-rad), transferred to nitrocellulose membranes by Turboblot (Bio-rad), and blotted with antibodies accordingly. For solubility test, heads of male flies were first homogenized in TNT lysis buffer supplemented with protease inhibitor cocktail (Roche) and centrifuged at 13,000 g for 15 min. The supernatants were collected as soluble fractions. The pellets were then washed with the same lysis buffer twice, followed by the addition of 8M urea and centrifugation for 20 min. The final supernatants were collected as insoluble fractions. The following antibodies were used for Western blotting: mouse anti-V5 (1:5000, Novus biologicals), rabbit anti-V5 (1:5000, Novus biological), mouse anti-tubulin (E7, 1:1000, DSHB), mouse antichickadee (chic 1J, 1:20, DSHB).
Larval ventral nerve cord preparation
Ventral nerve cord (VNC) dissection and staining were performed as previously described (44) . In brief, VNCs of 3 rd instar larvae were dissected in cold PBS and fixed in 4% PFA for 20 min. Fixed samples were blocked with blocking solution containing 5% normal goat serum and incubated with primary antibodies at 4 C overnight. They were then washed for three times with PBS with 0.3% Triton-X 100 (PBST), incubated with secondary antibodies at room temperature for 3 h, and mounted in Vectashield medium. At least three animals per genotype were analyzed.
Larval NMJ preparation
Third instar wandering larvae were dissected in HL3.1 buffer and prepared as previously described (45) . In brief, after dissection, larval fillets were fixed in 4% paraformaldehyde for 20 min, blocked for 30 min with PBTN buffer (0.3% Triton X100, 5% normal goat serum, and 200 mg/ml BSA) and incubated with primary antibodies at 4 C overnight. The fillets were then washed several times, incubated with secondary antibodies at room temperature for 1. 
Larval NMJ analysis
NMJs on muscle 4 of segment A2 and A3 were chosen for all analyses. For quantification of boutons (major, ghost, satellite), the axon was visualized by immunostaining for horse radish peroxidase (HRP) and post-synaptic densities were identified by positive staining for Discs-large (Dlg). Bead-like varicosities that were positive for HRP and apposed by Dlg were defined as major boutons. Ghost boutons were defined as small, HRP positive boutons lacking Dlg apposition. Satellite boutons were designated as small boutons growing from major boutons or axonal shafts which overlapped with Dlg. For filopodia analysis, thin filaments protruding from boutons and axonal shafts that were labeled with Lifeact-GFP were counted manually. For all analyses, the same settings and thresholds were applied to all genotypes during image acquisition and analysis. Images were acquired as Z-stacks under 60X magnification using an epifluorescence microscope (Ti, Nikon) equipped with a cooled CCD camera. Images were then deconvolved (Autoquant, MediaCybernetics). Maximum projections of deconvolved images were then analyzed using ImageJ software. BRP puncta were quantified by thresholding maximum projection images and using the analyze particle tool in ImageJ. The BRP intensity per puncta was determined by dividing the overall BRP intensity in the axon by the quantity of BRP puncta in thresholded maximum projection images. Expression of WT hPFN1 in motor neurons resulted in statistically significant shorter lifespans compared to the driver only control and compared to ALS-causative mutants. Expression of ALS-causative mutants also resulted in statistically significant shorter lifespans compared to the driver only control (Log-rank test: WT vs. control, P < 0.0001; WT vs. C71G, P < 0.0001; WT vs. M114T, P < 0.0001; C71G vs. control, P < 0.0001; C71G vs. M114T, P < 0.0001; M114T vs. control, P < 0.0001).
Behavioral analysis
One to three-day old male flies from corresponding crosses were collected and transferred to fresh food vials with a density of 20 flies per vial. Flies were allowed to recover from anesthesia for at least 2 days before any behavior analysis. Food was changed every 2 days to prevent flies from getting trapped. Negative geotaxis (climbing) assays were conducted in the early evenings on day 5, day 10, day 15, and day 20 after eclosion. To induce negative geotaxis, all the flies were gently tapped down to the bottom of empty vials and their ability to climb up was recorded using a standard video camera. The percentage of flies that climbed above 4 cm within 10 s was calculated. This measurement point was empirically determined using control flies. Between 160 and 240 flies were analyzed at each time point for each line. For lifespan analysis, 1-day-old male flies were collected into fresh food vials with density of 10 flies per vial. Flies were transferred to fresh food vials every 2 days and surviving flies were counted at the time. The survival of between 200 and 250 flies were examined for each line. Larval crawling assays were performed as previously described (46) . In brief, 3 rd instar wandering larvae were collected and transferred onto a 1% agarose plate. The crawling distance within 1 min was then measured. For each genotype, at least 20 animals from two crosses were tested.
Statistical analysis
One-way ANOVA followed by Tukey post-hoc test with multiple comparisons was used for all experiments except where indicated. Error bars represent S.E.M. throughout the study. n.s. not significant, *P < 0.05, **P < 0.005, ***P < 0.0005, ****P < 0.0001. P < 0.05 was considered statistically significant.
Supplementary Material
Supplementary Material is available at HMG online.
